At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective Randomized Trial to Compare Basal Bolus Therapies That Use Either Insulin Lispro Protamine Suspension or Insulin Glargine Together With Lispro Insulin in Patients With Type 2 Diabetes
In Brief
A Phase 3 clinical trial evaluating Insulin Glargine, Insulin Lispro Protamine Suspension (ILPS), and 1 other intervention for Diabetes Mellitus, Type 2. Completed, enrolled 374 participants across 50 sites in 10 countries.
Detailed Summary
This study is designed to look at if a basal bolus regimen of insulin lispro protamine suspension (ILPS) provides the same glycemic control as a basal bolus regimen of insulin glargine (when one basal bolus regimen is injected once daily together with insulin lispro injected 2-3 times daily).
Study Details
Timeline
Interventions
patient glucose-level dependent, injection, once daily in the evening, 24 weeks
patient glucose-level dependent, injection, once daily in the evening, 24 weeks
subcutaneous injections prior to meals, 24 weeks